Clinical Trials on Multiple Myeloma in Relapse in New Zealand
Total 839 results
-
Celularity IncorporatedRecruitingNeoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Hematologic Neoplasms | Physiological Effects of Drugs | Peripheral Nervous System Agents | Analgesics | Analgesics, Non-narcotic | Antimetabolites, Antineoplastic | Leukemia in Remission | Relapsed... and other conditionsUnited States
-
University of RochesterAmgenActive, not recruiting
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapse-Remitting Multiple SclerosisUnited States
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Georgetown UniversityNational Heart, Lung, and Blood Institute (NHLBI); Jazz PharmaceuticalsRecruitingAcute Myeloid Leukemia (AML) in RemissionUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Genta IncorporatedCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
NextCure, Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic Leukemia | Relapsed or Refractory Myelodysplastic SyndromeUnited States
-
University of RochesterRecruitingMultiple Myeloma | Prostate Cancer | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma (SMM)United States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Our Lady of Mercy Medical CenterUnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Roswell Park Cancer InstituteBristol-Myers SquibbActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Prelude TherapeuticsCompletedAdenoid Cystic Carcinoma | Refractory Chronic Myelomonocytic Leukemia | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory Diffuse Large B-cell Lymphoma | Relapsed/Refractory Advanced Solid Tumors | Relapsed/Refractory Myelodysplasia | Relapsed...United States
-
Massachusetts General HospitalCelgene; OncoPep, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterPaula and Rodger Riney Foundation; Plantable; M and M labs; VeggieDoctor; Sabinsa...RecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined SignificanceUnited States
-
Kronos BioTerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States, Spain
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
Vivolux ABTheradexTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Weill Medical College of Cornell UniversityTerminatedMultiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States